series-a
Stage
1
Investors
About
Mosaic Therapeutics is an oncology therapeutics company developing targeted small-molecule drug combinations using a specialised drug discovery platform. The company focuses on identifying biomarker-defined patient settings for its therapies.
Explore Mosaic Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.